VANCOUVER, British Columbia — Caser Luo, MD, discusses global safety data for Iluvien (fluocinolone acetonide intravitreal implant 0.19 mg) at the Association for Research in Vision and Ophthalmology meeting. In phase 4 post-market studies, the rate of IOP-related incisional surgery was “extremely low,” he said.
Uncategorized